Protech Announces Execution of LOI to Acquire a Profitable Leading Supplier of Respiratory Therapy Products and Services in the Southeastern U.S.

    NEXT STORY
    CB2 to Host Virtual Annual General Meeting on September 9, 2020
    PREV STORY
    Innovation Pharmaceuticals Announces Publication of Independent Research on Kevetrin, the Company’s p53 Drug Candidate, in Oncology Reports
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Bio-Path Holdings to Present Data at 2016 American Society of Clinical Oncology Annual Meeting

    HOUSTON, May 19, 2016 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company ...

    author_avatar
    NASDAQ Market News

    New Hope Animal Hospital Offers New Digital X-ray System for Dental Care

    DURHAM, N.C., Oct. 23, 2016 (GLOBE NEWSWIRE) -- A new digital X-ray system brings ...

    author_avatar
    NASDAQ Market News

    Upon Successful Completion of Cohort 3, Cellectar Biosciences Initiates Fourth Cohort of Its Phase I Clinical Trial of CLR 131 in Multiple Myeloma

    MADISON, Wis., Feb. 22, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused ...

    author_avatar
    NASDAQ Market News